Your health and safety remain our top priority: Learn about our Safe Care Commitment | Use our Prescreen app before arrival for faster entry | Read the COVID-19 Vaccine FAQs
Header Skipped.
The Brigham’s 7T MRI unit, just the second in the country to be approved for clinical use, revealed that a potential biomarker of brain inflammation in patients affected by multiple sclerosis is more common than previously thought.
The 16-hour surgery, involving a team of over 45 surgeons, nurses, anesthesiologists, residents and research fellows, and led by Bohdan Pomahac, MD, was the ninth face transplant procedure at the Brigham and the 15th nationwide.
David Louis, MD, has been appointed Mass General Brigham chief of enterprise pathology and will oversee the new enterprise service, Mass General Brigham enterprise laboratory service (MGBELS). Read More...
Connections among food intake, melatonin levels and genetics may be important for diabetes risk. Read More...
A combination of two drugs that open the floodgates to an immune system attack on cancer curtailed tumor growth in some patients with non-small cell lung cancer (NSCLC) that was resistant to a single immunotherapy agent, results from a recent clinica Read More...
